<DOC>
	<DOCNO>NCT01796691</DOCNO>
	<brief_summary>Comparing standard treatment versus optimize antiplatelet therapy outcomes measure .</brief_summary>
	<brief_title>The Bochum Optimizing Clopidogrel-Aspirin Therapy MORTality Study ( BOCLA-Mort )</brief_title>
	<detailed_description>The study aim evaluate optimized antiplatelet treatment use test treat algorithm ( whole blood aggregometry ) able improve clinical outcome patient compare standard treatment without platelet function testing .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>coronary stent implantation consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Clopidogrel</keyword>
	<keyword>aspirin</keyword>
	<keyword>low response</keyword>
	<keyword>platelet aggregation</keyword>
	<keyword>Acute Coronary Syndrome</keyword>
	<keyword>Coronary Stent Implantation</keyword>
</DOC>